Viewing Study NCT04659369


Ignite Creation Date: 2025-12-24 @ 10:57 PM
Ignite Modification Date: 2026-01-01 @ 10:25 PM
Study NCT ID: NCT04659369
Status: TERMINATED
Last Update Posted: 2024-04-09
First Post: 2020-11-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Pharmacokinetic, Safety, Immunogenicity and Efficacy of CMAB819 and Nivolumab in R/M HNSCC
Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module